A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
BackgroundBladder cancer (BC) is a molecular heterogeneous malignant tumor; the treatment strategies for advanced-stage patients were limited. Therefore, it is vital for improving the clinical outcome of BC patients to identify key biomarkers affecting prognosis. Ferroptosis is a newly discovered pr...
Main Authors: | Libo Yang, Chunyan Li, Yang Qin, Guoying Zhang, Bin Zhao, Ziyuan Wang, Youguang Huang, Yong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.686044/full |
Similar Items
-
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
by: Rui Zhu, et al.
Published: (2019-10-01) -
Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer
by: Hiroshi Fukushima, et al.
Published: (2018-10-01) -
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
by: Shuxiong Zeng, et al.
Published: (2019-06-01) -
Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
by: Fumitaka Koga, et al.
Published: (2018-09-01) -
A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
by: Jiao-chen Luan, et al.
Published: (2021-08-01)